This activity has been supported through an independent educational grant from Teva Pharmaceuticals.

Optimizing Treatment Regimens for Multiple Sclerosis: The Pharmacist’s Role in Advancing Patient Care

Mitra Habibi, PharmD

Clinical Assistant Professor

University of Illinois at Chicago

Clinical Pharmacist, Neurology

University of Illinois Hospital &

Health Sciences System

Chicago, Illinois

Educational Objectives

After participating in this activity, participants should be able to:

• Recall the incidence, etiology, and pathophysiology of multiple sclerosis (MS) and strategies to help patients understand the importance of treating early to slow disease progression.
• Discuss the available disease-modifying therapies and explain strategies to improve patient adherence to these agents, including patient assistance programs.
• Provide patient counseling information regarding medications available to treat exacerbations and manage symptoms of MS.
• Evaluate emerging therapies for the treatment of MS.

Target audience:

Pharmacists

Type of activity:

Knowledge

Release date:

December 8, 2014

Expiration date:

December 8, 2016

Estimated time to complete activity:

2.0 hours

Fee:

This lesson is offered free at www.pharmacytimes.org.

Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

This activity is approved for 2.0 contact hours (0.2 CEUs) under the ACPE universal activity number 0290-0000-14-110-H01-P. The activity is available for CE credit through December 8, 2016.